Simone Kardinahl

Angestellt, Global Head Biosimilar Technical Development, Sandoz AG

Basel, Schweiz

Fähigkeiten und Kenntnisse

Pharmaceutics
Small Molecules and Protein Therapeutics
Project Management
Research
Strategy Development
Process Development
Process Optimization
Change Management
Protein Biochemistry
Development
Microbiological Development
Large Scale Biotransformation Processes
GMP Manufacturing
GMP Requirements
Technology Implementation
Antibody Lead Discovery and Optimization
Cell Line Development
Clinical Supply of Biologics
Microbial Quality Control
Interdisciplinary Collaborations
Multi-Cultural Team Leadership

Werdegang

Berufserfahrung von Simone Kardinahl

  • Bis heute 1 Monat, seit Juni 2024

    Global Head Biosimilar Technical Development

    Sandoz AG

  • Bis heute 4 Jahre und 3 Monate, seit Apr. 2020

    Senior Vice President Development

    IDT Biologika GmbH
  • 3 Jahre und 6 Monate, Sep. 2016 - Feb. 2020

    Head of Antibody Lead Discovery & Cell & Protein Sciences

    Bayer

    Cell & Protein Sciences provides a strong R&D interface to enable successful and rapid clinical development, while laying the foundation for high performance leads with high quality antigens and screening solutions. Antibody Lead Discovery is in charge of defining and executing in Lead Finding Strategies for antibody generation projects. Phage Display as well as Immunization technologies are used and resulting antibody candidates are further optimized in terms of affinity / potency and immunogenicity.

  • 4 Jahre und 7 Monate, Feb. 2012 - Aug. 2016

    Head of Global Biological Development

    Bayer

    Global Biological Development in Wuppertal (currently 121 employees) develops biologicals for different therapeutic indications. The organization consists of Upstream Development, Downstream Development incl Analytics and two Pilot Plant Facilities. Submission of a Phase II Study in the shortest possible time. Successful start up of a Cell Culture Pilot Plant. Reorganization and strategic re-alignment of the department. Successful mitigation of a Single Supply Situation.

  • 3 Jahre und 1 Monat, Jan. 2009 - Jan. 2012

    Head of Microbiological Production and Development

    Bayer

    The Microbiological Production facility performs biotransformation reactions of steroids by use of bacteria, fungi and yeast. The production is run under cGMP and in a continuous shift-system. Significant cost reduction through process and yield stabilization, technology change. Stabilization of quality through establishing of real-time in-process-monitoring. Coordination of optimization processes across plants. Alignment on leadership principles and leadership roles.

  • 3 Jahre und 10 Monate, März 2005 - Dez. 2008

    Head of Microbiological Laboratory and Pilot Plant

    Bayer

    Development and transfer of fermentation and downstream processes from lab scale (10L/50L) to pilot scale (500L/ 5000L / 50.000L). Replacement of whole cell fermentation by enzyme catalysis resulting in significant cost of goods reductions. Head of Microbial Quality Control (water, drug substance) for the Bergkamen site. Team member of the change team, contributing to roll out of a „ Story of the Future” and vision as a guiding principles of the change.

  • 1 Jahr und 2 Monate, Jan. 2004 - Feb. 2005

    Head of Microbiological Development

    Bayer

    Optimization of fermentation parameters to increase volumetric productivity. Screening of microbial and fungal strains incl GMOs to improve yield/quality. Improvement of drug substance synthesis by introducing enzyme catalysis thus replacing multiple chemical steps.

  • 2 Jahre und 11 Monate, Feb. 2001 - Dez. 2003

    Scientist Fermentation Development

    Bayer

    Optimization of a whole cell fermentation process to stereospecifically dihydroxylate a steroid substrate. Qualification of raw materials for use in GMP processes.

  • 1 Jahr und 3 Monate, Okt. 1999 - Dez. 2000

    Head of Laboratory

    EUROIMMUN AG

    Purification of native antigens from different microbial, viral and human sources to enable establishment of diagnostic test systems based on antigen-antibody reactions. Successful purification of transglutaminase from human liver thus enabling establishment of a coeliac disease test system.

Ausbildung von Simone Kardinahl

  • University of Luebeck

    Summa cum laude / Universitätspreis der Universität zu Lübeck

  • Bis heute

    University of Hannover

    Summa cum laude / Universitätspreis der Universität zu Lübeck

Sprachen

  • Englisch

    Fließend

  • Deutsch

    Muttersprache

21 Mio. XING Mitglieder, von A bis Z